Societal CDMO to Report Financial Results for Third Quarter 2023 on November 8, 2023
01 nov. 2023 16h05 HE
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASD: SCTL), a contract development and manufacturing organization (CDMO)...
Societal CDMO Reports Inducement Grants for New Staff
05 oct. 2023 16h05 HE
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASDAQ: SCTL), a contract development and manufacturing organization (CDMO) dedicated to...
Cell-Easy is pleased to welcome Mrs. Gisele Deblandre, formerly CSO at MaSTherCell, as Chief Scientific Officer
28 sept. 2023 08h15 HE
|
CELL-EASY
Cell-Easy, a contract development and manufacturing organization (CDMO) in cell therapy, proudly announces the appointment of Mrs. Gisele Deblandre.
Cell and Gene Therapy Manufacturing Services Market worth $26.72 Billion, Globally, by 2030 – Comprehensive Study by The Insight Partners
27 sept. 2023 10h12 HE
|
The Insight Partners
Pune, India, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Cell & gene therapy (CGT) programs are rapidly advancing from research & development to clinical trials and commercial approval. Establishing...
Avid Bioservices to Participate in RBC Capital Markets Virtual CDMO Conference
26 sept. 2023 16h05 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Societal CDMO to Participate in RBC Capital Markets Virtual CDMO Conference
25 sept. 2023 16h05 HE
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO” or “Societal”; NASDAQ: SCTL), a contract development and manufacturing organization (CDMO)...
Societal CDMO Announces Corporate Restructuring
20 sept. 2023 16h05 HE
|
Societal CDMO, Inc.
SAN DIEGO and GAINESVILLE, Ga., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Societal CDMO, Inc. (“Societal CDMO”; NASDAQ: SCTL), a contract development and manufacturing organization (CDMO) dedicated to...
Rentschler Biopharma appoints Benedikt von Braunmuehl as Chief Executive Officer
19 sept. 2023 05h00 HE
|
Rentschler Biopharma SE
Benedikt von Braunmuehl, a transformational leader with a 30-year track record in the global healthcare industry, is named CEO Rentschler Biopharma SECompany also announces appointment of Tom Roberts,...
Global Active Pharmaceutical Ingredients CDMO Market 2023 - 2028: Key Players Driving API CDMO Market Expansion: Cambrex, Patheon, Lonza, Samsung Biologics and More
14 sept. 2023 07h58 HE
|
Research and Markets
Dublin, Sept. 14, 2023 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredients CDMO Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)" report has been added to ...
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2023
07 sept. 2023 16h05 HE
|
Avid Bioservices, Inc
-- Recorded First Quarter Revenue of $37.7 Million -- -- Signed $36 Million in Net New Business Orders Resulting in a Backlog of $189 Million -- -- Cell and Gene Therapy Facility Expansion Remains...